Welcome to Medications.com

Merck posts US$1.6 billion Q4 loss due to Vioxx deal, other charges - The Canadian Press

The maker of allergy and asthma pill Singulair and osteoporosis treatment Fosamax said the net loss amounted to 75 cents per share, compared with a year-ago ...

http://canadianpress.google.com/a... | Posted: Wed Jan 30 08:36:12 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea